Synonyms: IY-5511 | IY5511 | IY5511HCl | KB-146009 | Supect®
radotinib is an approved drug (South Korea (2012))
Compound class:
Synthetic organic
Comment: This drug is approved only in South Korea, for the treatment of chronic myeloid leukemia (CML), where its trade name is Supect.
It is Example 5 in patent US7501424 [1]. The marketed formulation contains the hydrochloride salt.. View more information in the IUPHAR Pharmacology Education Project: radotinib |
|
Download 2D Structure | |
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel